Evaluating the Safety and Efficacy of Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load

NCT01933594 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

59

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Romidepsin
DRUG: Placebo for Romidepsin

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)